Navigation Links
Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
Date:3/19/2012

ak syndromes, including diabetic macular edema (DME) which can impair vision and cause blindness The specific Optina dosages used in the trial are proprietary and subject to multiple patent filings.

Danazol, a derivative of the synthetic steroid ethisterone, was approved by the FDA in the 1970s for endometriosis and, more recently, for other chronic indications, including hereditary angioedema, ITP and fibrocystic disease of the breast.

About Ampio
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction. The product pipeline includes new uses for previously approved drugs and new molecular entities ("NMEs"). By concentrating on development of new uses for previously approved drugs, approval timelines, costs and risk of clinical failure are reduced because these drugs have strong potential to be safe and effective while their shorter development times can significantly increase near term value. A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize Ampio's product development programs. For more information about Ampio, please visit our website, www.ampiopharma.com.

Forward-Looking Statements
Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, successful commercialization and marketing of Zertane™ and the combination drug in Korea, and changes in business conditions and similar events.
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
2. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
3. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
4. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
5. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
6. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
7. Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
8. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
9. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
10. Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
11. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  PROMETRIKA, LLC, ... its offerings with the addition of pharmacovigilance services ... world leader in safety data collection and reporting, ... regulatory affairs professionals, and expert physicians, each with ... clinical interpretation and monitoring of safety trends. ...
(Date:6/2/2015)... Mass. , June 2, 2015  Psychemedics Corporation ... leader for over twenty-five years, announced the addition of ... In response to growing abuse concerns, the addition of ... and D-Amphetamine/Adderall® was added as an option to the ... Chairman and CEO stated:  "Sadly, more and more prescription ...
(Date:6/2/2015)... 2015  Accuray Incorporated (Nasdaq: ARAY ), announced ... at the Goldman Sachs 36th Annual Global Healthcare Conference ... on Wednesday, June 10, 2015 at 4:00pm PT.   ... be available on the Investor Relations page of the ... of the presentation will begin approximately one hour after ...
Breaking Medicine Technology:PROMETRIKA Announces the Availability of Pharmacovigilance Services 2Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... (Nasdaq: NBIX ) today announced the pricing ... its common stock at a price to the public ... from this offering, before deducting underwriting discounts and commissions ... to be approximately $77 million. The offering is expected ...
... 19, 2012  The Catalina Council of the Boy Scouts ... Arizona will complete the Chemistry Merit Badge requirements through ... based in Oro Valley, Arizona. Boy Scout participants will ... biologists and chemists, under whose guidance they can participate ...
Cached Medicine Technology:Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 2Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 3Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program 2Catalina Council Boy Scouts Partner With Sanofi US Tucson Research Center to Host First-Ever Chemistry Merit Badge Program 3
(Date:6/2/2015)... Mo. (PRWEB) June 02, 2015 With a ... Senior Living & Health Care has hired Leslie Young ... expansion of human resource initiatives to better understand and respond ... families in Tutera’s 47 communities in 13 states across the ... highest levels of personalized support to our residents, we are ...
(Date:6/2/2015)... DiaTech Oncology, provider of CorrectChemo®, the ... help oncologists provide personalized cancer treatment, has gained ... for its laboratories in the U.S. and Canada. ... the ‘Good Housekeeping’ seal of approval,” says Robert ... DiaTech. “It’s a rigorous inspection that confirms our ...
(Date:6/2/2015)... 2015 Though almost the entire Park family ... the disease rule their lives. Organizing and hosting the June ... living life to the fullest and spreading awareness of HHT. ... but I won't live my life in a bubble because ... you'd want is to look back on your life with ...
(Date:6/2/2015)... PA (PRWEB) June 02, 2015 For ... may be too exposed to harmful germs, chemicals and ... warranted. However, thanks to an inventor from Queens Village, ... SQUEEZE to provide an efficient, fun, hygienic way to ... of being exposed to bugs, chemicals and germs. Furthermore, ...
(Date:6/2/2015)... 02, 2015 The health care leaders ... pioneering provider of value-based care will now offer health ... and Sullivan Counties. The newly launched Crystal Run Health ... commercial Small Group Preferred Provider Organization (PPO) and Exclusive ... Healthcare’s Managing Partner and CEO, Hal Teitelbaum, MD, ...
Breaking Medicine News(10 mins):Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2Health News:Family brings awareness to genetic disease at first Memphis walk 2Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 3
... has the Potential to Save Thousands of Lives ... The US Advisory,Committee on Vaccines and Related ... use of rotavirus vaccines, potentially bringing,greater protection to ... sometimes,fatal cause of severe diarrhea. After reviewing data ...
... Program For Mesothelioma Patients, CHICAGO, Feb. 20 ... established the Mary and Bob Cosentino,Travel Grant Program ... this very grave asbestos-related cancer., Mesothelioma is ... lining of the lungs, heart or stomach until ...
... 2008, at 8:30 ... ... Inc. (NASDAQ:,NRMX; TSX: NRM) reports results for the fourth quarter and ... pharmaceutical and nutraceutical activities. The Company reports,for the fourth quarter, a ...
... Address Executive Weight Loss Coaching For Attorneys, ... http://www.leventhalweightloss.com -- the first in the ... an attorney, today announced that,its president and founder ... Frederick County, Maryland, Inc. at its March 4, ...
... /Xinhua-PRNewswire/ -- Venture Global Limited,unveils the VEGO Power ... VEGO Power Blocker, cellphone users could get,away from ... VEGO Power Blocker Kills the Invisible Killer by ... Blocker is a piece of ultra-thinned film, made ...
... OAKLAND, Calif., Feb. 20 Hundreds of,California healthcare workers ... wages and better benefits. The nursing,home and hospital workers ... in support of the historic 2008 campaign., For ... expire in the same,year, giving UHW extraordinary strength at ...
Cached Medicine News:Health News:FDA Advisory Committee Recommends US Approval of Rotavirus Vaccine 2Health News:Giving Patients a Lift 2Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 2Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 3Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 4Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 5Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 6Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 7Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 8Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 9Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 10Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 11Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 12Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 13Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 14Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 15Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 16Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 17Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 18Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 19Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 20Health News:Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives 21Health News:Leventhal Weight Loss Incorporated President Mark Leventhal to Address Frederick County Bar 2Health News:Venture Global Limited Introduces an Innovative Anti-Cellphone Radiation Sticker Named 'VEGO Power Blocker' 2Health News:UHW Launches Campaigns for More Than 75,000 Hospital and Nursing Home Workers 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: